IB
InSyte Bio develops precision gene editing technologies to enhance the efficiency of biopharmaceutical production processes. The company addresses the challenges of high costs and lengthy timelines in drug development by streamlining genetic modifications for improved yield and consistency.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- InSyte Bio develops precision gene editing technologies to enhance the efficiency of biopharmaceutical production processes. The company addresses the challenges of high costs and lengthy timelines in drug development by streamlining genetic modifications for improved yield and consistency.